Smart Scaffolds, Stronger Smiles Smarter Healing: AI-Boosted Multiphasic Scaffold Design for PDL Regeneration

September 22, 2026 updated by: Sana Ahmed Sakr, Misr University for Science and Technology

AI- Powered Multiphasic 3D Printed Scaffold for Periodontal Defect Regeneration

The periodontal ligament is vital for tooth support, and its loss, frequently resulting from periodontitis, trauma, or endodontic lesions, presents a significant clinical challenge; global cases of severe periodontitis increased by 91.54% from 1990 to 2021. Conventional monophasic scaffolds offer a uniform environment, limiting their efficacy in regenerating complex, multi-tissue structures like the periodontium. This study introduces an AI-enhanced, 3D multi-phasic scaffold to precisely restore the periodontal apparatus and overcome the limitations of non-uniform tissue growth seen in some multiphasic designs. The methodology involved sequential steps: high-resolution CBCT and intraoral scans to capture defect geometry; precise defect mapping to define the Target Regeneration Volume; and AI Mesh mixer implementation to generate three distinct, seamlessly graded lattice zones. This AI-driven design ensures Optimal Biomechanics (Precision) by perfectly matching the scaffold's stiffness to native tissue, thereby eliminating stress-shielding.

Study Overview

Detailed Description

Background: The global prevalence of severe periodontitis increased by 91.54% between 1990 and 2021, driven primarily by population growth and population ageing, and now affects more than one billion people worldwide . Left untreated, periodontitis progressively destroys the attachment apparatus and is a leading cause of tooth loss. Conventional regenerative therapies rely largely on monophasic scaffolds, which impose a single, uniform biological and structural environment and therefore struggle to reproduce the layered, multi-tissue architecture of the periodontium. Study Problem: The periodontium is a composite of three histologically and mechanically distinct tissues - alveolar bone, the periodontal ligament (PDL), and cementum - each of which requires a different stiffness, porosity, and biochemical microenvironment for optimal regeneration. Monophasic scaffolds cannot satisfy this requirement simultaneously, which frequently results in fibrous encapsulation, incomplete integration, or stress-shielding. Objectives: This thesis examines the design, fabrication rationale, and clinical evaluation of an Artificial-Intelligence (AI)-boosted three-dimensional (3D) multiphasic scaffold intended to achieve simultaneous, tailored regeneration of alveolar bone, PDL, and cementum through a graded lattice architecture matched to native tissue stiffness. Methodology: The target regeneration volume was defined using high-resolution Cone-Beam Computed Tomography (CBCT) and intraoral optical scanning, processed through AI-assisted defect-segmentation software. A tri-zonal multiphasic scaffold - an outer bone-directed zone, a middle PDL-directed zone, and an inner cementum-directed zone - was generated and produced by 3D 2 Smart Scaffolds, Stronger Smiles bioprinting using biocompatible polymer and bio-ceramic bio-inks, then surgically placed in patients with severe infrabony defects. Clinical and radiographic outcomes were assessed at 2, 6, and 12 months post-operatively.

Study Type

Interventional

Enrollment (Estimated)

1

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Normal Lab investigation

Exclusion Criteria:

  • Bone diseases , Bleeding disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1 patient

Patients underwent minimally invasive surgical intervention. Following preoperative diagnosis of severe infrabony defects exhibiting mobility and loss of periodontal support, a minimally invasive flap was elevated, and the defect was thoroughly debrided and prepared. The custom-printed multiphasic scaffold was seated into the defect with precision to ensure stability, and complete primary flap closure was achieved [

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing Depth
Time Frame: 12 months

the measured distance from the edge of the gum (gingival margin) to the bottom of the gum pocket or sulcus.

12 months
Bone quality , PDL formation
Time Frame: 2,6,12 month

refers to the density and architectural composition of the jawbone, which determines its strength and ability to stabilize a dental implant

2,6,12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2025

Primary Completion (Actual)

May 14, 2026

Study Completion (Estimated)

September 3, 2028

Study Registration Dates

First Submitted

September 15, 2026

First Submitted That Met QC Criteria

September 22, 2026

First Posted (Actual)

September 28, 2026

Study Record Updates

Last Update Posted (Actual)

September 28, 2026

Last Update Submitted That Met QC Criteria

September 22, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FWA00025573

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Not decided yet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe